Event-Driven Stocks

NEUROONE MEDICAL TECHNOLOGIES Corp

NMTCNasdaq

Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 3 good● 4 warning● 2 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$9.1M$3.5M$2.0M$171,169$178,146—
Operating income−$4.2M−$11.9M−$12.0M−$10.0M−$10.2M−$4.9M
Net income−$3.6M−$12.3M−$11.9M−$10.0M−$9.9M−$13.6M
Total assets$10.8M$5.4M$8.1M$12.8M$7.9M$4.8M
Total liabilities$3.7M$4.5M$1.8M$3.2M$1.4M$2.7M
Equity$7.1M$822,013$6.2M$9.6M$6.6M$2.1M
EPS (diluted)$-0.09$-0.46$-0.65$-0.63$-0.93—
Shares out.50.4M30.8M24.0M16.2M16.2M23.0M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−46.5%
Net margin
−39.6%
Return on equity
−51.0%
Return on assets
−33.4%
Return on capital (ROCE)
−49.8%
Liabilities / assets
34.4%
Debt / equity
0.53×
Book value / share
$0.14
Revenue growth (YoY)
163.5%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-19.57distress
Accruals / assets
−7.1%clean
Beneish M-Score
0.05elevated
Piotroski F-Score
6/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
55
/ 100
Profitability 0Growth 100Catalyst 33Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 2 severe● 4 warning● 3 good
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • Beneish M-Score elevated — earnings-manipulation screen flag
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202645,3021.2+63.0%
Apr 30, 202627,7951.0-79.8%
Apr 15, 2026137,2421.0+14.7%
Mar 31, 2026119,6221.0+36.8%
Mar 13, 202687,4651.0-18.6%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)